NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The innovation is particularly suited for bone and cartilage repair
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
Rivotril is the innovator/ reference brand of clonazepam and is widely prescribed for the management of neurological and psychiatric conditions
Subscribe To Our Newsletter & Stay Updated